Lilly's obesity triple pulls off 29% weight loss in trial Eli Lilly has ramped up the competition in weight-loss therapies by reporting the first pivotal data with its triple therapy retatrutide.

#Lilly #obesity #weightloss #PharmaNews #EliLilly #weightlosstherapies #retatrutide #TRIUMPH4trial #GLP1 #GIP #glucagon #subcutaneousinjection #weightreduction #WOMACscale #obesitytherapies #LillyCardiometabolicHealth #kneeosteoarthritis #obstructivesleepapnoea #OSA #Abivax #biotech
zurl.co/pf3xY